CYDY

CytoDyn (QB) Stock Price

2.28
-0.18 (-7.32%)
2.28
Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
CytoDyn Inc (QB) CYDY OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.18 -7.32% 2.28 16:00:02
Close Price Low Price High Price Open Price Previous Close
2.28 2.25 2.49 2.49 2.46
Bid Price Ask Price Spread News
2.28 2.29 0.01 2 -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
3,475 4,129,343 $ 2.3199 $ 9,579,863 4,454,192 0.261 - 10.01
Last Trade Time Type Quantity Stock Price Currency
16:01:07 formt 100 $ 2.2801 USD

CytoDyn (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.30B 569.32M 302.11M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
23.36M $ - 0.00% - -

more financials information »

CytoDyn (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CYDY Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week2.823.092.252.673,202,932-0.54-19.15%
1 Month3.383.872.252.983,314,814-1.10-32.54%
3 Months5.075.362.253.644,315,806-2.79-55.03%
6 Months3.2810.012.254.366,167,656-1.00-30.49%
1 Year0.32610.010.2613.295,235,3861.95599.39%
3 Years0.56510.010.05522.961,989,5361.72303.54%
5 Years0.8910.010.05522.811,283,3341.39156.18%

CytoDyn (QB) Description

CytoDyn Inc. is a late-stage biotechnology company developing innovative treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. Leronlimab is in a class of therapeutic monoclonal antibodies designed to address unmet medical needs in the areas of Human Immunodeficiency Virus (HIV), Cancer, and Immunology.


Your Recent History
USOTC
CYDY
CytoDyn (Q..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.